Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Biotin supplements significantly improved a young girl's uncombable hair.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

The treatment was ineffective in humans.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Co-trimoxazole may help treat autoimmune diseases.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Efalizumab can cause unexpected excessive hair growth.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.